Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-030414
Filing Date
2019-08-08
Accepted
2019-08-08 07:17:27
Documents
69
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 6-K ortx-6k_20190808.htm 6-K 1653600
2 EX-99.3 ortx-ex993_145.htm EX-99.3 210101
  Complete submission text file 0001564590-19-030414.txt   6998686

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT ortx-20190808.xml EX-101.INS 1392722
4 XBRL TAXONOMY EXTENSION SCHEMA ortx-20190808.xsd EX-101.SCH 61845
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20190808_cal.xml EX-101.CAL 51096
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20190808_def.xml EX-101.DEF 193893
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20190808_lab.xml EX-101.LAB 473564
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20190808_pre.xml EX-101.PRE 355507
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38722 | Film No.: 191007455
SIC: 2836 Biological Products, (No Diagnostic Substances)